Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Der Internist|November 11, 2021
[Acute porphyrias viewed differently]Jasmin Barman-Aksözen, Anna-Elisabeth Minder
Diabetes Research and Clinical Practice|June 4, 2013
Frequency of blood glucose testing in well educated patients with diabetes mellitus type 1: how often is enough?Anna Elisabeth Minder, Dominique Albrecht, Juliane Schäfer, et al.
Orphanet Journal of Rare Diseases|August 20, 2020
Increased phototoxic burn tolerance time and quality of life in patients with erythropoietic protoporphyria treated with afamelanotide - a three years observational studyJasmin Barman-Aksözen, Michèle Nydegger, Xiaoye Schneider-Yin, et al.
Life (Basel, Switzerland)|April 28, 2023
Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic ProtoporphyriaAnna-Elisabeth Minder, Xiaoye Schneider-Yin, Henryk Zulewski, et al.
Journal of Medical Case Reports|February 24, 2026
Biallelic pathogenic hydroxymethylbilane synthase gene variants of a neurodegenerative disorder with progressive cystic leukoencephalopathy: a case reportGabriel Schacht, Miriam Elbracht, Anna-Elisabeth Minder, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2024
Erythropoietic protoporphyrias: Pathogenesis, diagnosis and managementAnna-Elisabeth Minder, Louisa G Kluijver, Jasmin Barman-Aksözen, et al.
Praxis|April 20, 2026
[A malignant cause of metabolic decompensation]Anja Forrer, Mattia Giarrusso, Rahel Wright, et al.
International Journal of Environmental Research and Public Health|April 13, 2023
Quality-Adjusted Life Years in Erythropoietic Protoporphyria and Other Rare Diseases: A Patient-Initiated EQ-5D Feasibility StudyJasmin Barman-Aksözen, Anna-Elisabeth Minder, Francesca Granata, et al.
Pageof 2